美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
42291-476-60	42291-476	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230104	N/A	ANDA	ANDA209450	AvKARE	LUBIPROSTONE	24 ug/1	60 CAPSULE in 1 BOTTLE (42291-476-60)
42291-475-60	42291-475	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20230104	N/A	ANDA	ANDA209450	AvKARE	LUBIPROSTONE	8 ug/1	60 CAPSULE in 1 BOTTLE (42291-475-60)
65162-841-18	65162-841	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20211203	N/A	ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	8 ug/1	180 CAPSULE in 1 BOTTLE (65162-841-18)
65162-841-06	65162-841	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20211203	N/A	ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	8 ug/1	60 CAPSULE in 1 BOTTLE (65162-841-06)
65162-842-06	65162-842	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20211203	N/A	ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	24 ug/1	60 CAPSULE in 1 BOTTLE (65162-842-06)
65162-842-18	65162-842	HUMAN PRESCRIPTION DRUG	Lubiprostone	Lubiprostone	CAPSULE	ORAL	20211203	N/A	ANDA	ANDA209450	Amneal Pharmaceuticals LLC	LUBIPROSTONE	24 ug/1	180 CAPSULE in 1 BOTTLE (65162-842-18)